ClinicalTrials.Veeva

Menu

Muscle Memory After Treatment With Anabolic Substance Clenbuterol and Resistance Training in Humans

M

Morten Hostrup, PhD

Status

Enrolling

Conditions

Skeletal Muscle Physiology

Treatments

Drug: Clenbuterol
Drug: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT05692856
CLEN-MEM

Details and patient eligibility

About

The purpose of the project is investigate muscle memory and underlying mechanisms in humans following resistance training and use of the anabolic substance clenbuterol.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy men and women
  • BMI of <26 and normal ECG and blood pressure

Exclusion criteria

  • Smoking
  • Chronic disease,
  • Use of prescription medication
  • Pain due to current or previous musculoskeletal injury
  • Resistance training more than once per week in the 12 months leading up to the intervention
  • Current or previous use of prohibited anabolic substances

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

60 participants in 2 patient groups, including a placebo group

Clenbuterol
Experimental group
Description:
Participants are randomized to daily ingestion of clenbuterol for a period of 8 weeks, with or without supervised resistance training.
Treatment:
Drug: Clenbuterol
Placebo
Placebo Comparator group
Description:
Participants are randomized to daily ingestion of placebo for a period of 8 weeks, with or without supervised resistance training.
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Morten Hostrup

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems